Top picks in English

New Janssen boss in Denmark will use experiences from Lif and Astrazeneca

Julie Enevold Brooker will bring experiences from Astrazeneca and The Danish Association of the Pharmaceutical Industry (Lif) to the table when she starts her new job as head of pharmaceutical company Janssen's Danish department on 1. February.
Julie Enevold Brooker will use her past experience from Astrazeneca and Lif in her new job as head of Janssen-Cilag in Denmark. | Foto: Lif/PR
Julie Enevold Brooker will use her past experience from Astrazeneca and Lif in her new job as head of Janssen-Cilag in Denmark. | Foto: Lif/PR
af ALBERT RØNNING-ANDERSSON

The start of February marks a new start for Julie Enevold Brooker. After 15 years at industry giant Astrazeneca and a just over a year as chair of The Danish Association of the Pharmaceutical Industry (Lif), she is leaving these positions to concentrate on her new role as head of Janssen-Cilag in Denmark.

Allerede abonnent?Log ind her

Læs hele artiklen

Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

Med din prøveperiode får du:

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
    • Skal indeholde mindst 8 tegn samt tre af disse: Store bogstaver, små bogstaver, tal, symboler
    Skal indeholde mindst 2 tegn
    Skal indeholde mindst 2 tegn

    Få fuld adgang til dig og dine kollegaer

    Start et gratis virksomhedsprøveabonnement

    Del artikel

    Relaterede artikler

    Tilmeld dig vores nyhedsbrev

    Vær på forkant med udviklingen. Få den nyeste viden fra branchen med vores nyhedsbrev.

    Nyhedsbrevsvilkår

    Forsiden lige nu

    Læs også

    Job